What the World’s First Pig to Human Heart Transplant Could Mean for the Future of Transplants
On January 7, the world's first genetically-modified pig heart transplant occurred. The surgery was not a clinical trial, but a procedure granted emergency authorization by the US Food and Drug Administration due to the patient's critical condition. What will it mean for the future of transplants?
Exploring the Principle of Ion Exchange Chromatography and Its Applications
Ion-exchange chromatography (IEX) is a class of liquid chromatography used to separate organic and inorganic molecules, in particular biomolecules. In this article, we explore how the technique works and its applications in this context.
Why Biotechnology Companies Should Leverage Novel and Competitive Opportunities With CDMOs To Serve a Greater Population
Dr. Gayatri Sharma explores how expanding partnership focuses could help to reach, treat and heal the greatest number of people in the most efficient manner possible.
Closing the Vaccine Gap
Here, we explore some of the reasons behind vaccine hesitancy and highlight potential ways to combat the issue.
Existing and Emerging Lab 4.0 Technologies in 2021
In this article, we look to the technologies and innovations that will define the future of science.
Sustainable Science and The Road to Net Zero
My Green Lab's mission is to build a culture of sustainability in science. In this interview with CEO James Connelly, we find out how the non-profit is striving to achieve this goal.
COVID-19 Childhood Vaccines: Why Don’t They Last a Lifetime, Like the Measles Shot?
Sophie Prosolek explores why some vaccines last a lifetime, while others do not, for Technology Networks.
Atomic Absorption Spectroscopy, Principles and Applications
In this article, we explore atomic absorption spectroscopy, what is is, how it works, strengths and limitations and the areas in which the technique finds utility.
Promises and Challenges of Target-Based Drug Discovery
In this article, we will compare the two key drug discovery approaches, the challenges and opportunities of each and the future of target-based drug discovery.
Designing Vaccines With Reverse Vaccinology
Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen.